RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1

Leuk Res. 2016 Jun:45:68-74. doi: 10.1016/j.leukres.2016.03.008. Epub 2016 Mar 31.

Abstract

MEK/ERK signal pathway was required for the differentiation of granulocytes, megakaryocytes and erythrocytes. Recently, MEK/ERK cascade was reported to be involved in all-trans retinoic acid (ATRA) induced differentiation in acute promyelocytic leukemia (APL) cells. However, the upstream and downstream molecules of MEK/ERK signal pathway in this cell model remains to be elucidated. In this work, we showed that RAF-1 was activated and the blockade of RAF-1 activation attenuated MEK/ERK activation as well as ATRA-induced differentiation. ATRA-enhanced protein levels of C/EBPβ, C/EBPε and PU.1, which were required for differentiation in APL cells, were suppressed by the specific inhibitor of MEK. However, MEK inhibition had no effect on the degradation of PML-RARα fusion protein or the restoration of PML nuclear bodies by ATRA treatment. Taken together, our study suggested that RAF-1/MEK/ERK cascade was involved in ATRA-induced differentiation in APL cells through enhancing the protein level of C/EBPβ, C/EBPε and PU.1.

Keywords: Acute promyelocytic leukemia; All-trans retinoic acid; Differentiation; MEK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • CCAAT-Enhancer-Binding Protein-beta / biosynthesis
  • CCAAT-Enhancer-Binding Protein-beta / drug effects
  • CCAAT-Enhancer-Binding Proteins / biosynthesis
  • CCAAT-Enhancer-Binding Proteins / drug effects
  • Cell Differentiation / drug effects*
  • Cell Line, Tumor
  • Granulocytes / drug effects
  • Granulocytes / pathology
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Leukemia, Promyelocytic, Acute / metabolism
  • Leukemia, Promyelocytic, Acute / pathology*
  • MAP Kinase Signaling System / physiology*
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins c-raf / physiology*
  • Trans-Activators / biosynthesis
  • Trans-Activators / drug effects
  • Tretinoin / pharmacology*

Substances

  • Antineoplastic Agents
  • CCAAT-Enhancer-Binding Protein-beta
  • CCAAT-Enhancer-Binding Proteins
  • Proto-Oncogene Proteins
  • Trans-Activators
  • proto-oncogene protein Spi-1
  • CEBPE protein, human
  • Tretinoin
  • Proto-Oncogene Proteins c-raf